Hale's Medications & Mothers' Milk 2025-2026

The peerless resource that lactation consultants consult and trust!

Filled with authoritative, current, and evidence-based information, the 2025-2026 edition of this internationally renowned drug reference remains the gold standard on the safe use of medications in breastfeeding mothers. Extensively updated throughout, the 2025-2026 edition encompasses numerous new and updated drugs and delivers current knowledge on relevant diseases, vaccines, and syndromes as they impact infant risk.

Written by world-renowned clinical pharmacologists, the highly detailed manual relies on the most current evidence-based studies to evaluate the relative risk of commonly used drugs. It is precisely organized for quick information retrieval and features the respected guidance of Dr. Hale's Lactation Risk Categories (LRC), listing safe alternatives for drugs one is currently taking or might need to take in the future. For ease of access to information, the reference highlights key points and savvy tips and presents common abbreviations, illustrative diagrams, concise information on evaluating the infant, and more. Purchase includes online access via most mobile devices or computers.

New to the 2025-2026 Edition:

• 66 New drugs
• 338 medications updated with new data
• 10 drugs with FDA updates
• 575 medications updated with new information
• 84 existing drugs with updated LRC

Key Features:

• Delivers current, evidence-based information on over 1,300 drugs, diseases, vaccines, and syndromes
• Includes key points and savvy tips about breastfeeding and medications for quick reference

• Incorporates recent updates to Dr. Hale's world renowned Lactation Risk Categories (LRC)
• Provides critical updates on weight loss drugs such as Wegovy and Ozempic, heart failure drugs such as Entresto, medications for anxiety, postpartum depression, and much more.

• Lists common abbreviations and drugs in easily accessible alphabetical order
• Discusses adult concerns, adult dose, pediatric concerns, infant monitoring, and drug alternatives